- Generic name
- Rabeprazole Sodium
- Strength
- 20 mg
- Dosage form
- Capsule
- Manufactured by
- Advanced Chemical Industries PLC
Paricel 20 Capsule
About Paricel 20 Capsule
Paricel 20 is a capsule containing 20 mg of rabeprazole sodium, used for acid-related stomach and oesophageal conditions. It belongs to the proton pump inhibitor group of medicines and is made by Advanced Chemical Industries PLC.
There are 48 brands of Rabeprazole Sodium listed in Bangladesh. The lowest listed price is Acifix 10 mg Sprinkle Capsule at ৳ 3.50 per unit.
What is Paricel 20 Capsule?
Paricel 20 is a capsule form of rabeprazole sodium 20 mg, a proton pump inhibitor. It reduces the amount of acid produced by the stomach. It is used to treat active duodenal ulcer, active benign gastric ulcer, and symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GERD). It is also used for long-term management of GERD and for moderate to very severe GERD symptoms. The doctor decides the dose and course of treatment. The capsule should be swallowed whole as directed by the doctor. Do not change the dose without medical advice.
Uses of Paricel 20
Paricel 20 is used for several acid-related conditions. These include active duodenal ulcer and active benign gastric ulcer. It is also used for symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GERD). Another use is long-term management of GERD. It may also be prescribed for symptomatic treatment of moderate to very severe GERD. Your doctor will confirm whether it is suitable for your condition.
How to use Paricel 20
Take Paricel 20 exactly as your doctor tells you. Swallow the capsule whole with water; do not chew or crush it. The doctor decides the dose and how long you should take it. Do not stop or change the dose on your own, even if you feel better. If you forget a dose, ask your doctor or pharmacist what to do. Keep the capsule in its pack and store it as directed.
Side effects of Paricel 20
Paricel 20 is generally well tolerated, but it can cause side effects in some people. These may include headache, diarrhoea, abdominal pain, vomiting, constipation, dry mouth, increased or decreased appetite, muscle pain, drowsiness, and dizziness. If you experience any side effect that bothers you or does not go away, tell your doctor or pharmacist. Do not self-treat side effects without medical advice.
Safety and precautions
Before taking Paricel 20, tell your doctor if you are pregnant, planning pregnancy, or breastfeeding, as it is contraindicated in pregnancy and during breastfeeding. Also tell your doctor about any allergies and all other medicines you take, because rabeprazole can interact with some drugs. A symptomatic response does not rule out stomach or oesophageal cancer, so your doctor may need to exclude this first. Long-term treatment needs regular check-ups. PPI use, especially high doses over a long time, may modestly increase the risk of hip, wrist, and spine fractures, mainly in older people. Ask your doctor about your risks.
Frequently asked questions
What does the capsule form and 20 mg strength mean?
Paricel 20 comes as a capsule, which is a solid dosage form you swallow whole. The 20 mg strength means each capsule contains 20 mg of rabeprazole sodium. Your doctor will decide how many capsules you need and for how long. Do not change the dose yourself.
What is Paricel 20 used for and what kind of medicine is it?
Paricel 20 is a proton pump inhibitor. It is used for active duodenal ulcer, active benign gastric ulcer, symptomatic erosive or ulcerative GERD, long-term GERD management, and moderate to very severe GERD symptoms. It works by reducing stomach acid. Your doctor will confirm if it is right for you.
What does the generic name rabeprazole sodium mean?
The generic name rabeprazole sodium identifies the active ingredient in Paricel 20. Rabeprazole is a proton pump inhibitor that reduces acid production in the stomach. Different brands may contain the same generic medicine. Always check with your doctor or pharmacist before switching brands.
Can I take Paricel 20 with other medicines?
Some medicines can interact with rabeprazole, including ketoconazole, itraconazole, and atazanavir. Tell your doctor or pharmacist about all medicines, supplements, and herbal products you use. They will check for interactions and advise whether any adjustment is needed. Do not start or stop other medicines without asking them first.
Indications
- Active duodenal ulcer
- Active benign gastric ulcer
- Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
- Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance) ... Read more
- Active duodenal ulcer
- Active benign gastric ulcer
- Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
- Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
- Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- Zollinger-Ellison Syndrome
- In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.
Pharmacology
Dosage & Administration
Erosive or Ulcerative Gastro-Esophageal Reflux Disease (GERD): The recommended oral dose for this condition is 20 mg to be taken once daily for four to eight weeks.
Gastro-Esophageal Reflux Disease Long-term Management (GERD Maintenance): For long-term management, a maintenance dose of rabeprazole sodium 20 mg or 10 mg once daily can be used depending upon patient response.
Symptomatic treatment of moderate to very severe Gastro-Esophageal Reflux Disease (symptomatic GERD): 10 mg once daily in patients without oesophagitis. If symptom control has not been achieved during four weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using an on-demand regimen taking 10 mg once daily when needed.
Treatment of GERD in pediatric patients 1 to 11 years of age (Less than 15 kg): 5 mg once daily for 12 weeks with the option to increase to 10 mg if inadequate response.
Treatment of GERD in pediatric patients 1 to 11 years of age (15 kg or more): 10 mg once daily for 12 weeks.
Zollinger-Ellison Syndrome: The recommended adult starting dose is 60 mg once a day. The dose may be titrated upwards to 120 mg/day based on individual patient needs. Single daily doses up to 100 mg/day may be given. 120 mg dose may require divided doses, 60 mg twice daily. Treatment should continue for as long as clinically indicated.
Eradication of H. pylori: Patients with H. pylori infection should be treated with eradication therapy. The following combination given for 7 days is recommended. Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily and amoxicillin 1g twice daily.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
- Symptomatic response to therapy with Rabeprazole does not preclude the presence of gastric or oesophageal malignancy, therefore the possibility of malignancy should be excluded prior to commencing treatment with Rabeprazole 20 mg Gastro-resistant Tablets.
- Patients on long-term treatment (particularly those treated for more than a year) should be kept under regular surveillance.
- Proton pump inhibitors, especially if used in high doses and over long durations (>1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10–40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care and they should have an adequate intake of vitamin D and calcium.
- A risk of cross-hypersensitivity reactions with other proton pump inhibitor or substituted benzimidazoles cannot be excluded.
- Patients should be cautioned that Rabeprazole gastro-resistant tablets should not be chewed or crushed, but should be swallowed whole.
- There have been post marketing reports of blood dyscrasias (thrombocytopenia and neutropenia). In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
- Hepatic enzyme abnormalities have been seen in clinical trials and have also been reported since market authorisation. In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
- No evidence of significant drug related safety problems was seen in a study of patients with mild to moderate hepatic impairment versus normal age and sex matched controls. However because there are no clinical data on the use of rabeprazole in the treatment of patients with severe hepatic dysfunction the prescriber is advised to exercise caution when treatment with Rabeprazole 20mg Gastro-resistant. Tablets is first initiated in such patients.
- Co-administration of atazanavir with Rabeprazole is not recommended.
- Treatment with proton pump inhibitors, including rabeprazole, may possibly increase the risk of gastrointestinal infections such as Salmonella, Campylobacter and Clostridium difficile.
Influence on vitamin B12 absorption: Rabeprazole sodium, as all acid-blocking medicines, may reduce the absorption of vitamin B12 (cyanocobalamin) due to hypo- or a- chlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced vitamin B12 absorption on long-term therapy or if respective clinical symptoms are observed.
Subacute cutaneous lupus erythematosus (SCLE): Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Rabeprazole. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.
Interference with laboratory tests: Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, Rabeprazole 20mg Gastro-resistant Tablets treatment should be stopped for at least 5 days before CgA measurements. If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.
Overdose Effects
Storage Conditions
Alternative brands of Rabeprazole Sodium
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.